Cargando…

Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy

The Food and Drug Administration requires contemporaneous controls to compare clinical outcomes for participants receiving experimental gene therapy or gene editing clinical trials. However, developing a contemporaneous cohort of rare diseases requires multiple person-hours. In a single referral cen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cronin, Robert M., Wuichet, Kristin, Ghafuri, Djamila L, Hodges, Brock, Chopra, Maya, He, Jing, Niu, Xinnan, Kassim, Adetola A., Wilkerson, Karina, Rodeghier, Mark, DeBaun, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Health Services and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393740/ https://www.ncbi.nlm.nih.gov/pubmed/36350716 http://dx.doi.org/10.1182/bloodadvances.2022008692

Ejemplares similares

Most adults with severe HbSC disease are not treated with hydroxyurea
por: Ghunney, William Kwesi, et al.
Publicado: (2023)

World Health Organization’s Growth Reference Overestimates the Prevalence of Severe Malnutrition in Children with Sickle Cell Anemia in Africa
por: Ghafuri, Djamila L., et al.
Publicado: (2020)

Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease
por: Chopra, Maya, et al.
Publicado: (2022)

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
por: Idris, Ibrahim M., et al.
Publicado: (2022)

Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis
por: Hodges, Brock, et al.
Publicado: (2022)

2484: Establishment of the Tennessee-sickle cell disease network as a mechanism for engaging a rare disease population in patient centered outcomes research
por: Mayo-Gamble, Tilicia, et al.
Publicado: (2018)

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries
por: Klein, Lauren Jane, et al.
Publicado: (2023)

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting
por: Klein, Lauren J., et al.
Publicado: (2022)

Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume
por: Jones, R. Sky, et al.
Publicado: (2023)

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study
por: Cronin, Robert M., et al.
Publicado: (2019)

Improved Guideline Adherence With Integrated Sickle Cell Disease and Asthma Care
por: McClain, Brandi L., et al.
Publicado: (2016)

COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals
por: Singh, Ashima, et al.
Publicado: (2021)

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
por: Johnson, Kate M., et al.
Publicado: (2022)

Outcomes before and after providing interdisciplinary hematology and pulmonary care for children with sickle cell disease
por: Zeno, Rachel N., et al.
Publicado: (2022)

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease
por: Mucalo, Lana, et al.
Publicado: (2023)

Adapting medical guidelines to be patient-centered using a patient-driven process for individuals with sickle cell disease and their caregivers
por: Cronin, Robert Michael, et al.
Publicado: (2018)

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
por: Hsu, Peter, et al.
Publicado: (2021)

Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
por: Amonoo, Hermioni L., et al.
Publicado: (2022)

Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease
por: Chaturvedi, Shruti, et al.
Publicado: (2022)

Management of Sickle Cell Disease Super Utilizers
por: Johnson, Gary A.
Publicado: (2017)

Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review
por: Badawy, Sherif M, et al.
Publicado: (2018)

A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD
por: Cronin, Robert M., et al.
Publicado: (2023)

The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease
por: Cronin, Robert M., et al.
Publicado: (2023)

The aged worker in contemporaneity
por: Mendes, Aida Maria de Oliveira Cruz, et al.
Publicado: (2021)

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
por: Wood, William A., et al.
Publicado: (2020)

Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials
por: Hantel, Andrew, et al.
Publicado: (2021)

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
por: Stojkov, Igor, et al.
Publicado: (2021)

How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
por: Nieuwlaat, Robby, et al.
Publicado: (2021)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes
por: LoCastro, Marissa, et al.
Publicado: (2021)

Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States
por: Kuczmarski, Thomas M., et al.
Publicado: (2022)

Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
por: Delforge, Michel, et al.
Publicado: (2022)

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
por: Verneris, Michael R., et al.
Publicado: (2021)

ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology
por: Wood, William A., et al.
Publicado: (2021)

Code status transitions in patients with high-risk acute myeloid leukemia
por: Abrams, Hannah R., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
por: Wang, Rong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9q03b2rg4l8tancbrkg9mjvc8f